Novartis Ag (NVSEF) Income from Non-Controlling Interests (2009 - 2026)

Novartis Ag has disclosed Income from Non-Controlling Interests across 16 years of filings, most recently posting $415.0 million for Q1 2026.

• Income from Non-Controlling Interests for Q1 2026 came in at $415.0 million, up 13733.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $415.0 million (up 8200.0% YoY), and the FY2025 annual result was $419.0 million, up 658.67% from the prior year.
• Income from Non-Controlling Interests came in at $415.0 million for Q1 2026 at Novartis Ag, up from -$5.0 million in the prior quarter.
• In the past five years, Income from Non-Controlling Interests ranged from a high of $422.0 million in Q3 2025 to a low of -$17.0 million in Q2 2025.
• The 5-year median for Income from Non-Controlling Interests is $79.5 million (2022), against an average of $102.4 million.
• Across the five-year window, Income from Non-Controlling Interests slumped 350.0% in 2025 and soared 13733.33% in 2026, its largest moves.
• Novartis Ag's Income from Non-Controlling Interests stood at -$2.0 million in 2022, then soared by 200.0% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then plunged by 350.0% to -$5.0 million in 2025, then jumped by 8400.0% to $415.0 million in 2026.
• The last three Income from Non-Controlling Interests figures came in at $415.0 million (Q1 2026), -$5.0 million (Q4 2025), and $422.0 million (Q3 2025), per Business Quant data.